Person

Prof.dr. R. Pieters

Pagina-navigatie:

Completed research projects

(the most recent research is at the top)
Supervisor	The Social Psychology of Envy: An inquiry into the causes and consequences
Project leader	Characterization of a novel BCRABL-like subtype with high relapse-risk in pediatric acute lymphoblastic leukemia
Project leader	Molecular diagnosis of polymorphism of cytochrome P450 isoenzymes for optimalisation of chemotherapy in childhood cancer
Supervisor	Chemotherapy Induced Intestinal Mucositis: from bench to bed
Supervisor	Endocrine Effects of the Treatment for Acute Lymphoblastic Leukemia and Hodgkin's Lymphoma in Childhood
Supervisor	Molecular-genetic Insights in Pediatric T-cell Acute Lymphoblastic Leukemia
Supervisor	Identification of Prognose Genetic Factors in Pediatric T-cell Acute Lymphoblastic Leukemia
Supervisor	Molecular determinants of asparaginase resistance in childhood leukemia
Project leader	Polymorphism in the glucocorticoid receptor genes and abnormal receptors as determinants of resistance to glucocorticoid induced apoptosis
Project leader	Training for Parents of Children with Newly Diagnosed Cancer: a Randomised Controlled Trial.
Project leader	Prognostic relevance of molecular-genetic markers in pediatric T-cell acute lymphoblastic leukemia and identification of drugable targets
Project leader	Can multi-color flowcytometric immunophenotyping replace PCR-based detection of minimal residual disease in childhood acute lymphoblastic leukemia?
Project leader	Clinical application of genome-wide gene expression profiling in pediatric ALL; sub-classification, relapse prediction and causes of drug resistance
Project leader	Involvement of HLXB9 and ETV6 in childhood acute leukemia and its relation to leukemogenesis and treatment outcome
Project leader	Molecular alterations in the reduced folate carrier gene, multidrug resistance protein-mediated efflux and folate compartmentation: impact on cellular folate homeostasis and activity of antifolate drug in childhood leukemia
Project leader	Definition of risk groups in infant acute lymphoblastic leukemia by prospective analysis of immunobiological characteristics, genetic abnormalities, drug resistance and minimal residual disease